WITHDRAWN: Anti-TNF-induced IL-27 modulates regulatory T cell responses in patients with IBD that respond to therapy
Raphael Sanches Peres(Universidade de São Paulo), Fiona Powrie(Kennedy Center), Claire Pearson(Wayne State University), Kelsey Jones(Imperial College London), Yisu Gu(University of Oxford), Ashwin Jainarayanan(University of Exeter), Matthias Friedrich(Nuffield Orthopaedic Centre), Calliope A. Dendrou(University of Oxford), Elizabeth H. Mann(Nuffield Orthopaedic Centre), Christopher D. Buckley(Queen Elizabeth Hospital Birmingham), Dominik Trzupek(Centre for Human Genetics), Holm H. Uhlig(University of Oxford), Mathilde Pohin(Nuffield Orthopaedic Centre), Tom Thomas(Nuffield Orthopaedic Centre), Simon Travis(University of Oxford), Charlotte Rich‐Griffin(University of Warwick), Ricardo C. Ferreira(Centre for Human Genetics), John A. Todd(University of Oxford)
Cited by 2
Related Papers
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
|Nature|2007|9.6k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease
|Nature Genetics|2017|1.5k
Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes
|Nature Genetics|2007|1.5k